Irinotecan-induced interstitial pneumonia.


Autoria(s): Michielin O.; Udry E.; Périard D.; Matzinger O.; Lobrinus J.A.; Stupp R.
Data(s)

2004

Identificador

http://serval.unil.ch/?id=serval:BIB_FAADB151B2AE

isbn:1470-2045 (Print)

pmid:15120670

doi:10.1016/S1470-2045(04)01471-8

isiid:000221291400022

Idioma(s)

en

Fonte

Lancet Oncology, vol. 5, no. 5, pp. 322-324

Palavras-Chave #Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Brain Neoplasms/drug therapy; Camptothecin/administration & dosage; Camptothecin/adverse effects; Dacarbazine/administration & dosage; Dacarbazine/analogs & derivatives; Diagnosis, Differential; Frontal Lobe; Glioblastoma/drug therapy; Humans; Lung Diseases, Interstitial/chemically induced; Lung Diseases, Interstitial/diagnosis; Male
Tipo

info:eu-repo/semantics/article

article